Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-May 2021. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1776941000001114 | Amikacin liposomal | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1776951000001112 | Amikacin liposomal (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Amikacin liposomal | Is a | Substance with aminoglycoside structure and antibacterial mechanism of action | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Amikacin liposomal 590mg nebuliser dispersion vials with device | Has specific active ingredient | True | Amikacin liposomal | Inferred relationship | Existential restriction modifier | |
| Arikayce liposomal 590mg nebuliser dispersion vials with Lamira Nebuliser Handset (Insmed Ltd) | Has specific active ingredient | True | Amikacin liposomal | Inferred relationship | Existential restriction modifier | |
| Amikacin liposomal 590mg nebuliser dispersion vials with device 28 vial | Has specific active ingredient | True | Amikacin liposomal | Inferred relationship | Existential restriction modifier | |
| Arikayce liposomal 590mg nebuliser dispersion vials with Lamira Nebuliser Handset (Insmed Ltd) 28 vial 4 x 7 vials | Has specific active ingredient | True | Amikacin liposomal | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR